Recently, citrullinated peptides targeting vimentin and α-enolase have been certified to have anti-tumor immune effects by triggering a CD4+ T cell response, building evidence for the potential immunogenicity of protein citrullinated in tumors 47, 48. Here, CD4 is linked to neoplasm.